Short answer
TransMedics Group, Inc. (TMDX) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 results announced February 24, 2026: full figures in Exhibit 99.1.
TransMedics Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 results announced February 24, 2026: full figures in Exhibit 99.1
- Filing "furnished" not "filed": standard earnings disclosure, not subject to Section 18 liability
- TMDX operates in organ transplant technology; results cover critical growth period for commercial scaling
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TransMedics Group, Inc. 8-K filings
Get the next TMDX 8-K as it lands
Follow TMDX for push alerts, or ask the research agent what this filing means.